SCHEMBL29649646

SCHEMBL29649646

O=c1cccnn1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29649650 1.00
SCHEMBL27275825 0.80 IDO1 (0.45)
SCHEMBL1155525 0.79 IDO1 (0.43)
SCHEMBL4489558 0.78
SCHEMBL11983401 0.76 RAB9A (0.44)
SCHEMBL30297732 0.76 LMNA (0.44)
SCHEMBL12569419 0.75 IDO1 (0.43)
SCHEMBL10366086 0.75 IDO1 (0.43)
SCHEMBL27977295 0.75 MAPK1 (0.57)
SCHEMBL13654974 0.75 ALDH1A1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024129395-A1 BTK INHIBITORS GWYNANT THERAPEUTICS, INC. (US) 2024-06-20 WO disclosed
US-20220162169-A1 6-OXO-1,6-DIHYDROPYRIDAZINE PRODRUG DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2022-05-26 US disclosed